Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.

Abstract

BACKGROUND AND OBJECTIVES Fibroblast growth factor 23 (FGF23) is an independent risk factor for mortality in patients with ESRD. Before FGF23 testing can be integrated into clinical practice of ESRD, further understanding of its determinants is needed. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS In a study of 67 adults undergoing peritoneal dialysis, we… (More)
DOI: 10.2215/CJN.04290511

Topics

4 Figures and Tables

Slides referencing similar topics